Sekine C, Aoyagi Y, Suzuki Y, Ichida F
Department of Internal Medicine, Niigata University School of Medicine, Japan.
Br J Cancer. 1987 Sep;56(3):371-5. doi: 10.1038/bjc.1987.205.
The reactivity of alpha-1-antitrypsin (AAT) with Lens culinaris agglutinin (LCA) was studied by crossed immuno-affinity electrophoresis of the sera of 246 subjects from 6 groups (acute virus hepatitis, chronic hepatitis, liver cirrhosis, hepatocellular carcinoma (HCC), carcinoma metastatic to the liver and normal controls). Two species of AAT (LCA-reactive and -nonreactive species) were detected on crossed immuno-affinity electrophoresis in a gel containing LCA. The percentages of LCA-reactive species of AAT in neoplastic diseases of the liver were significantly higher than those in benign liver diseases and normal controls. There was no correlation between the percentage of LCA-reactive species of AAT and serum AAT concentration in any group. Furthermore, in studying 15 pairs of serum samples before and after the subsequent development of HCC, the percentage of LCA-reactive species of AAT after HCC occurrence was significantly higher than that before, although there was no statistically significant difference between the serum AAT concentration before and after development of the disease. The latter 15 patients were all of the normal protease inhibitor phenotype (PiMM) and no change in phenotype was observed before and after the development of HCC. The results indicate that measurement of the reactivity of AAT with LCA can be a useful marker for the diagnosis of HCC and carcinoma metastatic to the liver, especially when serum concentrations of alpha-foetoprotein or other tumour markers are within the normal ranges.
通过对6组(急性病毒性肝炎、慢性肝炎、肝硬化、肝细胞癌(HCC)、肝转移癌和正常对照)246名受试者血清进行交叉免疫亲和电泳,研究了α-1-抗胰蛋白酶(AAT)与菜豆凝集素(LCA)的反应性。在含有LCA的凝胶中进行交叉免疫亲和电泳时,检测到两种AAT(LCA反应性和非反应性种类)。肝脏肿瘤性疾病中AAT的LCA反应性种类百分比显著高于良性肝脏疾病和正常对照。在任何组中,AAT的LCA反应性种类百分比与血清AAT浓度之间均无相关性。此外,在研究15对HCC发生前后的血清样本时,HCC发生后AAT的LCA反应性种类百分比显著高于发生前,尽管疾病发生前后血清AAT浓度无统计学显著差异。后15例患者均为正常蛋白酶抑制剂表型(PiMM),HCC发生前后未观察到表型变化。结果表明,检测AAT与LCA的反应性可作为诊断HCC和肝转移癌的有用标志物,尤其是当甲胎蛋白或其他肿瘤标志物的血清浓度在正常范围内时。